1262615-69-9

Basic information

• Product Name: 2-(3',4'-dihydroxyphenyl)-5,7-dihydroxy-3-β-D-[2'',6''-di-O-(4-fluorophenylacetyl)]galactosyl-4H-chromen-4-one
• Synonyms: 2-(3',4'-dihydroxyphenyl)-5,7-dihydroxy-3-β-D-[2'',6''-di-O-(4-fluorophenylacetyl)]galactosyl-4H-chromen-4-one
• CAS NO: 1262615-69-9
• Molecular Weight: 736.634
• Mol File: 1262615-69-9.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 2-(3',4'-dihydroxyphenyl)-5,7-dihydroxy-3-β-D-[2'',6''-di-O-(4-fluorophenylacetyl)]galactosyl-4H-chromen-4-one(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(3',4'-dihydroxyphenyl)-5,7-dihydroxy-3-β-D-[2'',6''-di-O-(4-fluorophenylacetyl)]galactosyl-4H-chromen-4-one(1262615-69-9)
• EPA Substance Registry System: 2-(3',4'-dihydroxyphenyl)-5,7-dihydroxy-3-β-D-[2'',6''-di-O-(4-fluorophenylacetyl)]galactosyl-4H-chromen-4-one(1262615-69-9)

Safety Data

• Hazardous Substances Data: 1262615-69-9(Hazardous Substances Data)

Upstream product

• 742062-20-0 2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-5,7-dihydroxy-3-(2,3,4,6-tetraacetyl-β-D-galactopyranosyl)-4H-chromen-4-one 
• 3068-32-4 1-bromo-1-deoxy-2,3,4,6-tetra-O-acetyl-a-D-galactopyranoside 
• 357194-03-7 2-(2,2-diphenylbenzo[1,3]dioxol-5-yl)-3,5,7-trihydroxychromen-4-one 
• 1262615-56-4 5,7-dibenzyloxy-2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-3-β-D-[2'',6''-di-O-(4-fluorophenylacetyl)]galactosyl-4H-chromen-4-one 
• 1262615-43-9 5,7-dibenzyloxy-2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-3-β-D-[2'',6''-di-O-(4-fluorophenylacetyl)-3'',4''-O-isopropylidene]galactosyl-4H-chromen-4-one 
• 1262615-38-2 5,7-dibenzyloxy-2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-3-β-D-(3'',4''-O-isopropylidene)galactosyl-4H-chromen-4-one 
• 1262615-37-1 5,7-dibenzyloxy-2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-3-β-D-galactosyl-4H-chromen-4-one 
• 1262615-36-0 5,7-dibenzyloxy-2-(2,2-diphenylbenzo[d][1,3]dioxol-5-yl)-3-β-D-tetraacetylgalactosyl-4H-chromen-4-one 

Relevant articles and documents

NOVEL FLAVANONE DERIVATIVE

Provided is a novel antimicrobial agent. More specifically, provided is a novel antimicrobial agent capable of effectively acting on various resistant bacteria such as VSSA, MRSA, VISA, VRE, and VRSA. A novel flavanone derivative having a six-membered monosaccharide derivative, specifically, a glucose derivative or a galactose derivative is capable of effectively acting on the bacteria. More specifically, a compound represented by the general formula (I) is capable of effectively acting on the bacteria. (In the formula: X represents a six-membered monosaccharide derivative; and Y is substituted by a hydroxyl group.)